These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 12861964)

  • 1. Selection of the first-time dose in humans: comparison of different approaches based on interspecies scaling of clearance.
    Mahmood I; Green MD; Fisher JE
    J Clin Pharmacol; 2003 Jul; 43(7):692-7. PubMed ID: 12861964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interspecies allometric scaling: prediction of clearance in large animal species: part II: mathematical considerations.
    Martinez M; Mahmood I; Hunter RP
    J Vet Pharmacol Ther; 2006 Oct; 29(5):425-32. PubMed ID: 16958788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Approaches for predicting human pharmacokinetics using interspecies pharmacokinetic scaling.
    Kang HE; Lee MG
    Arch Pharm Res; 2011 Nov; 34(11):1779-88. PubMed ID: 22139680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interspecies allometric scaling. Part I: prediction of clearance in large animals.
    Mahmood I; Martinez M; Hunter RP
    J Vet Pharmacol Ther; 2006 Oct; 29(5):415-23. PubMed ID: 16958787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interspecies scaling and comparisons in drug development and toxicokinetics.
    Ings RM
    Xenobiotica; 1990 Nov; 20(11):1201-31. PubMed ID: 2275215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interspecies scaling of therapeutic monoclonal antibodies: initial look.
    Ling J; Zhou H; Jiao Q; Davis HM
    J Clin Pharmacol; 2009 Dec; 49(12):1382-402. PubMed ID: 19837907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interspecies scaling: predicting clearance of drugs in humans. Three different approaches.
    Mahmood I; Balian JD
    Xenobiotica; 1996 Sep; 26(9):887-95. PubMed ID: 8893036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A brief survey of first-in-human studies.
    Wexler D; Bertelsen KM
    J Clin Pharmacol; 2011 Jul; 51(7):988-93. PubMed ID: 20671293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extrapolating from animal studies to the efficacy in humans of a pretreatment combination against organophosphate poisoning.
    Levy A; Cohen G; Gilat E; Kapon J; Dachir S; Abraham S; Herskovitz M; Teitelbaum Z; Raveh L
    Arch Toxicol; 2007 May; 81(5):353-9. PubMed ID: 17009047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translating dosages from animal models to human clinical trials--revisiting body surface area scaling.
    Blanchard OL; Smoliga JM
    FASEB J; 2015 May; 29(5):1629-34. PubMed ID: 25657112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of maximum drug concentration and area under the time-concentration curve between humans and animals for oral and intravenous investigational drugs.
    Fujita T; Matsumoto Y; Ozaki M; Majima M; Kumagai Y; Ohtani Y
    J Clin Pharmacol; 2006 Jun; 46(6):674-92. PubMed ID: 16707414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allometric scaling of clearance in dogs.
    Martinez M; Mahmood I; Hunter RP
    J Vet Pharmacol Ther; 2009 Oct; 32(5):411-6. PubMed ID: 19754905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deriving a data-based interspecies assessment factor using the NOAEL and the benchmark dose approach.
    Bokkers BG; Slob W
    Crit Rev Toxicol; 2007 Jun; 37(5):355-73. PubMed ID: 17612951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating the safe starting dose in phase I clinical trials and no observed effect level based on QSAR modeling of the human maximum recommended daily dose.
    Contrera JF; Matthews EJ; Kruhlak NL; Benz RD
    Regul Toxicol Pharmacol; 2004 Dec; 40(3):185-206. PubMed ID: 15546675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of allometrically predicted pharmacokinetic parameters in humans: role of species selection.
    Tang H; Mayersohn M
    Drug Metab Dispos; 2005 Sep; 33(9):1288-93. PubMed ID: 15919852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic allometric scaling of antibodies: application to the first-in-human dose estimation.
    Mahmood I
    J Pharm Sci; 2009 Oct; 98(10):3850-61. PubMed ID: 19177515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interspecies scaling: role of protein binding in the prediction of clearance from animals to humans.
    Mahmood I
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1439-46. PubMed ID: 11185664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interspecies extrapolation in risk analysis.
    Travis CC
    Ann Ist Super Sanita; 1991; 27(4):581-93. PubMed ID: 1820730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative requirements for exploratory clinical trials -- eIND, eCTA and microdosing.
    Muller PY
    Adv Drug Deliv Rev; 2011 Jun; 63(7):511-7. PubMed ID: 21034787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designing first-in-human dose of coagulation factors: application of pharmacokinetic allometric scaling.
    Mahmood I
    Haemophilia; 2014 Jan; 20(1):32-8. PubMed ID: 23855969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.